Genica Channel For The World

Breakthrough interactive atlas offers pathway to precision medicine for TBI patients Researchers at Phoenix's Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that may eventually help doctors use precision medicine to target treatments for traumatic brain injury (TBI) patients – and could replace the existing uniform treatment model. news-medical.net/news/20240716/Breakthrough-interactive-atlas-offers-pathway-to-precision-medicine-for-TBI-patients.aspx --- @Genica1

Weill Cornell researchers define three Parkinson's subtypes with machine learning Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson's disease based on the pace at which the disease progresses. news-medical.net/news/20240716/Weill-Cornell-researchers-define-three-Parkinsons-subtypes-with-machine-learning.aspx --- @Genica1

Bridging chemistry and computing to combat cancer Vincent Zoete is developing computer tools to fight cancer. The chemist, who heads two groups at the University of Lausanne and the Swiss Institute of Bioinformatics, predicts the effects of new drugs. news-medical.net/news/20240716/Bridging-chemistry-and-computing-to-combat-cancer.aspx --- @Genica1

Study identifies RFC4 as key player in nasopharyngeal carcinoma Lichuan Wu et al., at Medical College of Guangxi University, China, presented a comprehensive study on the role of replication factor C subunit 4 (RFC4) in nasopharyngeal carcinoma (NPC), a type of epithelial cancer commonly associated with Epstein-Barr virus infection. news-medical.net/news/20240712/Study-identifies-RFC4-as-key-player-in-nasopharyngeal-carcinoma.aspx --- @Genica1

New study reveals the genetic cause of Parkinson's disease According to Science Alert, neuroscientists from Johns Hopkins University have recently discovered a new treatment for Parkinson's disease using an FDA-approved cancer drug. news-medical.net/news/20240711/New-study-reveals-the-genetic-cause-of-Parkinsons-disease.aspx --- @Genica1

Salads under scrutiny: Study reveals contamination risks and solutions in ready-to-eat salads The research paper highlights critical contamination points in the production of ready-to-eat salads and discusses solutions to ensure microbiological safety and health. news-medical.net/news/20240710/Salads-under-scrutiny-Study-reveals-contamination-risks-and-solutions-in-ready-to-eat-salads.aspx --- @Genica1

Study examines the frequency and preventability of adverse drug events in outpatient settings Rachel L. Wasserman, PharmD, of the Department of General Internal Medicine at Brigham and Women's Hospital, is the lead author and David W. Bates, MD, medical director of Clinical and Quality Analysis for Mass General Brigham and Co-Director of the Center for Artificial Intelligence and BioInformatics for Mass General Brigham, is the senior author of a new study published in BMJ Quality & Safety, "Frequency and preventability of adverse drug events in the outpatient setting." news-medical.net/news/20240709/Study-examines-the-frequency-and-preventability-of-adverse-drug-events-in-outpatient-settings.aspx --- @Genica1

New 'band-aid' measures body biomarkers that indicate health or disease through sweat Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a 'band-aid' or plaster that measures body 'biomarkers' that can indicate health or disease through sweat, paving the way for a new non-invasive and effective way for patients to monitor their health. news-medical.net/news/20240708/New-band-aid-measures-body-biomarkers-that-indicate-health-or-disease-through-sweat.aspx --- @Genica1

Advancing genomics research: An inside look at Azenta Life Sciences' new Oxford Genomics Laboratory This interview delves into the capabilities and services of Azenta Life Sciences' new Oxford Genomics Laboratory, discussing its role in advancing genomic research in the UK, the unique setup process, and future expansion plans. news-medical.net/news/20240708/Advancing-genomics-research-An-inside-look-at-Azenta-Life-Sciences-new-Oxford-Genomics-Laboratory.aspx --- @Genica1

Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses Researchers discovered that interferon-stimulated SAMD9L restricts HIV-1 and other lentiviruses by inhibiting viral translation and endosomal trafficking, while SAMD9 enhances HIV-1 replication. news-medical.net/news/20240707/Novel-antiviral-protein-SAMD9L-blocks-HIV-1-and-other-lentiviruses.aspx --- @Genica1